Wettable Magnesium Stearate. What Are Customers Looking for in Selecting Pharmaceutical Lubricants?

Similar documents
LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

Technical brochure StarLac

Re-compaction properties of lactose and microcrystalline cellulose

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

STARCH Application Data

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE. Technical brochure MicroceLac 100

Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1

SCIENTIFIC DISCUSSION. Efavirenz

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

Critical material properties for the design of robust drug products : excipient functionality related characteristics

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

The unlocked synergy of DFE Pharma MCC

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation

Permeability Study on Cellulose Acetate Butyrate Coating Film

Manufacturer of High Purity Chemicals PRODUCT LIST

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig

REVISION OF MONOGRAPH ON TABLETS. Tablets

Technical brochure CombiLac

Formulation and evaluation of oro-dispersible tablets of lafutidine

To study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.

LAB.2. Tablet Production Methods

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

Solving the solubility challenge: A key success factor of pharmaceutical formulations

Narrowing the gap between clinical capsule formulations and commercial film-coated tablets

Designed and manufactured specifically for pharmaceutical capsule filling

Content Uniformity of Direct Compression tablets

Improving Micromeritic Properties of Ibuprofen: An Agglomeration Approach

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Effect of Compaction Forces on Powder Bed Permeability of Magnesium Silicate "Common Excipient Mixture"

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Rationale of and Experience with the Expert System

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

Excipient Considerations for Continuous Manufacturing Implementation

Available online through

Formulation and Evaluation

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

TABLET DESIGN AND FORMULATION

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Food supplement manufacture

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

Formulation and evaluation of sublingual tablets of lisinopril

PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods

Preparation and Evaluation of Silymarin Controlled Release Tablets Prepared Using Natural Gums

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2009/42

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

FORMULATION CHOICE. How and why they are chosen. Dr Andy Fowles On behalf of ECPA Specification Expert Group

Functionality of GalenIQ 721 as excipient for direct compression tablets

Formulation Development and Evaluation of Cholecalciferol (Vitamin D3) Granules and Tablets

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Primellose is an excellent choice as superdisintegrant in ODT applications

The influence of lactose particle size on dry powder inhalation performance

In-Vitro Bioequivalence Studies for Oral Solid Dose products using the Morphologi G3-ID

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

Direct Compression Formulation Using Starch 1500 with Ranitidine HCl (150 mg) Tablets, Film Coated with Opadry II (85F Series)

3. Drug or plant or excipients profile

Assessment of Low Dose Content Uniformity of Indomethacin in Excipient Blends Using FT-Raman Mapping Spectroscopy

J.Ayyappan et al, /J. Pharm. Sci. & Res. Vol.2 (7), 2010,

Pharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency

Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets

Formulation and evaluation of immediate release salbutamol sulphate

xvi LIST OF TABLES S.NO Title of the Table Page No 2.1 Composition of zolmitriptan formulations Powder flow properties and angle of repose 58

A. General Appearance

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

STUDY OF THE DETERIORATION OF ASPIRIN IN THE PRESENCE OF VARIOUS EXCIPIENTS

Journal of Advanced Scientific Research. Development of Directly Compressible Ascorbic Acid Tablet Using Novel Excipients

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B.

Formulation and In-Vitro Evaluation of Leflunomide Tablet with Enhanced Dissolution

Current FDA Perspective on Excipients NJPhAST Meeting September 15, 2016

Analysis and stability of polymorphs in tablets: The case of Risperidone

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

Etat des travaux du GDP

Research Article Preformulation Studies for Generic Omeprazole Magnesium Enteric Coated Tablets

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

CHAPTER 8 HYDROGEL PLUG FORMULATION AND EVAUATION

The Particle Design of Cellulose and the Other Excipients for a Directly Compressible Filler-Binder

Journal of Chemical and Pharmaceutical Research

Case Study 1: Pharmaceutical Development of EXUBERA

FLORITER. New Technology for Innovative Formulation Design.

FORMULATION DEVELOPMENT AND EVALUATION OF FENOFIBRATE CAPSULES

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

Available online Research Article

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

Technical Transfer- A tablet process transfer case study. Presented by Jonathan King 4 July, 2016

African Journal of Pharmaceutical Research & Development

IJRPC 2012, 2(3) Chowdary et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

Journal of Chemical and Pharmaceutical Research, 2017, 9(1): Research Article

Commercial Bulleting Aloe Flakes

Transcription:

Wettable Magnesium Stearate Presented By: Richard Pudlo P.E. Principal Chemical Engineer April 29 th, 2015 What Are Customers Looking for in Selecting Pharmaceutical Lubricants? Meet USP/.NF monograph definition Demonstrate manufacturing process control Demonstrate measureable benefits, e.g.: Powder flowability Blend uniformity Tableting ease Tablet quality Provide product quality attributes for regulatory filings needs (QbD) Provide application data and technical support Made with suitable vegetable source materials 2 1

Most Used Excipients Magnesium Stearate (MgSt) is used in >2,500 pharmaceutical products The most used excipient in top 200 Rx drugs 120 108 Most Used Excipients No in Top 200 Rx Drugs 100 80 60 40 20 77 61 49 45 40 36 25 22 21 20 20 20 19 19 19 0 3 Mallinckrodt s Pharmaceutical Lubricants Products Magnesium Stearate Monohydrate Magnesium Stearate Dihydrate (not currently available) Stear-O-Wet TM (SOW) Unique Attributes Purity Consistency Functionality 4 2

Mallinckrodt s Magnesium Stearate Monohydrate MgSt Codes 2257, 5712 and 1726 are vegetable source lubricants produced by a precipitation process with tight control over particle physical properties. Certified to meet NF/EP/JP and FCC specifications. Dihydrate MgSt Code 1729 can be produced through a proprietary process (U.S. Pat 7,385,068) and will meet NF/EP/JP specifications. The dihydrate crystalline structure is thought to contribute to better lubricity during tableting. Not Commercially Available. Stear-O-Wet Code 8577 is a finely divided, uniform, spray-dried homogeneous mixture of Magnesium Stearate (NF/EP/JP) and Sodium Lauryl Sulfate (SLS) (NF/EP). This SLS-treated lubricant exhibits improved wetting characteristics, facilitating disintegration and dissolution of drug substances in tablets. 5 Mallinckrodt s Magnesium Stearate Monohydrate High purity Well-defined crystalline state Consistent physical properties Particle size distribution Surface area Morphology Minimum Lot-to-lot variability Consistent Performance 6 3

Typical Monohydrate Particle Size Distribution 7 Typical Mallinckrodt Monohydrate Physical Properties Particle Size Distribution Density g/cc Code SSA, m 2 /gm d50, um d90, um Apparent Tapped 2257 6.0 8.0 10.6 13.6 20 24 0.11 0.13 0.21 0.31 5712 6.5 9.0 8.6 11.0 17 24 0.11 0.13 0.21 0.29 1726 6.1 6.7 21 24 37 41 0.12 0.14 0.27 0.34 8 4

SEM of Mallinckrodt MgSt Monohydrate 1000X 2500X 9 Magnesium Stearate Monohydrate and Dihydrate are Stable Pseudopolymorphs The dihydrate is not an intermediate in the formation of trihydrate from anhydrous form. [V. Swaminathan and D. Kilsig AAPS PharmSciTech 2001; 2 (4) article 28.] 10 5

Thermal Analysis (DSC) Mallinckrodt highly pure magnesium stearate monohydrate and dihydrate materials Common on the market are mixtures of variable ratios of monoand dihydrate and other crystalline forms. 11 Major Customers Experiences and University Research Inconsistent hydrate forms of MgSt were linked to variable sticking properties of the tablets. Specifying the hydration state should be part of MgSt specifications. Capping issues were observed in making tablets when MgSt contained a mixture of hydration states. Tablets with no sticking issues used monohydrate and MgSt was better distributed in the tablet matrix. Sticking blends in roller compaction was linked to MgSt hydration state and vendor sources. Mallinckrodt MgSt monohydrate had no sticking issues. A study at Long Island University showed that pure MgSt monohydrate or dihydrate exhibited lower lubricity index and thus lower tendency to over-lubrication than a mixture of hydration forms. 12 6

Stear-O-Wet A Stearate that will wet Stear-O-Wet A co-processed material of MgSt and sodium lauryl sulfate (94/6) 14 7

Stear-O-Wet A Wettable Magnesium Stearate Lubricant Stear-O-Wet is a finely divided, uniform, spray-dried homogeneous mixture of Magnesium Stearate (MgSt) and Sodium Lauryl Sulfate (SLS) manufactured by Mallinckrodt. Because the surfaces of MgSt particles are modified with SLS, Stear-O-Wet exhibits enhanced wettability. 15 SEM and Particle Size/Size Distribution of Lubricants Stear-O-Wet Mixture of MgSt/SLS (94/6) 16 8

Powder X-Ray Diffraction Patterns 17 Stear-O-Wet provides better wetting than a mixture of MgSt and SLS 15 Sec 0.5% mix 0.5% SOW 1% mix 1% SOW 30 Sec 45 Sec Individual 95% Cls For Mean Based on Pooled StDev Level N Mean StDev ---------+---------+---------+---------+ Stear-O-Wet 24 40.21 8.36 (-----+-----) Mixture 24 56.25 8.06 (-----+----) ---------+---------+---------+---------+ Pooled StDev = 8.21 42.0 48.0 54.0 60.0 18 9

Comparison of Stear-O-Wet with MgSt/SLS Mixture Comparison of Powder Flow and Compression Characteristics of MCC/Lactose (1:1)/APAP (5 %) at lubricant level of 0.5, 1.0 and 2.0 % and blending times of 2, 5, and 10 minutes. Stear-O-Wet Mixture of MgSt/SLS (94/6) Powder Densification Lower Higher Powder Cohesiveness Lower Higher Lubricity Higher Lower Powder Compressibility Higher Lower at Low Pressure Compatibility Higher Lower Total Wettability Higher Lower Dissolution Not Distinguishable Not Distinguishable 19 Conclusion Stear-O-Wet consists of agglomerated, spray-dried powder particles. The presence of SLS provides enhanced wettability, but the lubricity of MgSt remains when fresh MgSt surfaces are generated during the blending. Results from basic flow energy, wall friction angle, compression/ejection force measurement suggest Stear-O-Wet exhibits better lubricity than a mixture of MgSt/SLS. The wettable nature of Stear-O-Wet can overcome the hydrophobic effect of MgSt when used as a lubricant. 20 10

Stear-O-Wet Tableting Studies Magnesium Stearate vs. Stear-O-Wet Study Acetaminophen blend, 500 mg tablets Lubricants: Magnesium Stearate 0.25% and 1.0% Stear-O-Wet 0.25% and 1.0% Standard and 3x blend times Riva Mini-press Target 15 KN compression force Standard Dissolution Testing 22 11

Dissolution w/ Low Levels of Lubricant 23 Dissolution w/ Higher Levels of Lubricant 24 12

Level of Lubricant Effect on Dissolution 25 Results With Normal Blend Times At 1% lubrication level Stear-O-Wet dissolution is twice as fast in the first 11 minutes than Magnesium Stearate. 1% Stear-O-Wet had comparable dissolution times to 0.25% Magnesium Stearate, all else being identical. 0.25% Stear-O-Wet improved early dissolution compared to 0.25% Magnesium Stearate Stear-O-Wet can help under lubricated formulations with less impact on dissolution time than Magnesium Stearate. 26 13

Dissolution w/ Low Level Lubricant, 3x Blend Time 27 Dissolution w/ Higher Lubrication, 3x Blend Time 28 14

Results with Extended Blend Times At 1% Stear-O-Wet had significantly faster dissolution compared to Magnesium Stearate. At 0.25% Stear-O-Wet had similar dissolution to Magnesium Stearate. Dissolution with SOW is less impacted by blend time. Stear-O-Wet can help under lubricated formulations with less impact on dissolution than Magnesium Stearate since it is more readily wetted. 29 Simulated Gastric Fluid Scenario 30 15

Simulated Gastric Fluid Scenario Results Stear-O-Wet facilitated a much faster initial dissolution due to wettability of the tablet. High levels of Magnesium Stearate can slow dissolution even in Simulated Gastric Fluid case. 31 Some Tableting Definitions Applied Pressure: the pressure the top punch applies to make a tablet Transmitted Pressure: the pressure measured by the bottom punch Transmitted Pressure/Applied Pressure = a measure of Lubricity or T/A The closer the T/A value is to one, the better the Lubricity of the formulation. Ejection force: the force as measured to eject the tablet out of the die. 32 16

Modest Differences for Ejection Forces 33 Stear-O-Wet Is a Better Lubricant 34 17

Tablet Press Measurement Results Tablet ejection force is modestly higher for Stear-O-Wet at 0.25% and about equal at 1.0% content. Blend time has little impact on Stear-O-Wet for press ejection forces T/A Ratio for Stear-O-Wet indicates it is a better lubricant regardless of amount of lubricant added or blend time. 35 Tablet Wetting Study 0.25% Magnesium Stearate vs 0.25% Stear-O-Wet Blend Compap L and lubricant and tablet at 15 KN 35 microliters of 0.28% methylene blue indicator in water via pipette Watch for: Wicking of water across tablet Absorption of water into the tablet 36 18

Watch Carefully! 37 Stear-O-Wet vs. Magnesium Stearate in Water Half a vial of deionized water Stear-O-Wet added to one vial Magnesium Stearate added to second vial Vials inverted twice and gently shaken. 38 19

The Video 39 Lubricant in Water Results Stear-O-Wet wets quickly and completely slurry is created!! Magnesium Stearate for most part stays on top of the water very little is wetted 40 20

Lubricant in Water Results Using consistent and high quality lubricant in making tablets is critically important to tablet quality Lubricant material properties particle size/size distribution, specific surface area and crystalline state are critical quality attributes influencing powder flow and compaction, and QbD consideration The lubricity of Mg-stearate depends on its crystalline states and hydration matters. Mg stearate monohydrate is a stable crystalline state, and pure MgSt monohydrate is made consistently by Mallinckrodt Stear-O-Wet is a wettable co-processed lubricant containing MgSt monohydrate and sodium lauryl sulfate (94/6 by wt). It is particularly suitable for overcoming disintegration and dissolution issues caused by tablet lubricants. 41 Thank You Mallinckrodt, the M brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. 2014 Mallinckrodt. 42 21